LSERS
SUPN icon

Louisiana State Employees Retirement System’s Supernus Pharmaceuticals SUPN Stock Holding History

Louisiana State Employees Retirement System’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Hold
25,400
– – 0.02% 1007
2026
Q1 		$1.31M Sell
25,400
-900
-3% -$45.8K 0.02% 839
2025
Q4 		$1.31M Buy
26,300
+500
+2% +$24.3K 0.02% 848
2025
Q3 		$1.23M Sell
25,800
-400
-2% -$16.1K 0.02% 877
2025
Q2 		$826K Buy
26,200
+200
+0.8% +$6.41K 0.02% 1081
2025
Q1 		$852K Sell
26,000
-700
-3% -$24.8K 0.02% 1057
2024
Q4 		$965K Buy
26,700
+100
+0.4% +$3.52K 0.02% 1027
2024
Q3 		$829K Sell
26,600
-1,100
-4% -$34.3K 0.02% 1144
2024
Q2 		$741K Buy
27,700
+600
+2% +$17.4K 0.01% 1155
2024
Q1 		$924K Sell
27,100
-200
-0.7% -$5.96K 0.02% 1038
2023
Q4 		$790K Sell
27,300
-500
-2% -$13.3K 0.02% 1135
2023
Q3 		$766K Sell
27,800
-800
-3% -$24.4K 0.02% 1070
2023
Q2 		$860K Buy
28,600
+3,400
+13% +$119K 0.02% 1003
2023
Q1 		$913K Sell
25,200
-500
-2% -$19.2K 0.02% 881
2022
Q4 		$917K Buy
25,700
+100
+0.4% +$3.48K 0.03% 846
2022
Q3 		$867K Sell
25,600
-200
-0.8% -$6.51K 0.03% 813
2022
Q2 		$773K Sell
25,800
-100
-0.4% -$2.86K 0.02% 987
2022
Q1 		$768K Buy
25,900
+200
+0.8% +$6.13K 0.02% 1080
2021
Q4 		$749K Buy
25,700
+100
+0.4% +$3.03K 0.02% 1126
2021
Q3 		$683K Buy
25,600
+1,700
+7% +$45.6K 0.02% 1141
2021
Q2 		$736K Sell
23,900
-100
-0.4% -$3.07K 0.02% 1095
2021
Q1 		$628K Sell
24,000
-300
-1% -$8.39K 0.02% 1160
2020
Q4 		$611K Sell
24,300
-100
-0.4% -$2.15K 0.02% 1061
2020
Q3 		$508K Buy
24,400
+10,090
+71% +$229K 0.02% 970
2020
Q2 		$340K Sell
14,310
-200
-1% -$4.42K 0.02% 999
2020
Q1 		$261K Sell
14,510
-3,480
-19% -$73.1K 0.02% 1000
2019
Q4 		$427K Sell
17,990
-1,410
-7% -$34.2K 0.02% 1085
2019
Q3 		$533K Sell
19,400
-100
-0.5% -$2.96K 0.03% 913
2019
Q2 		$622K Sell
19,500
-100
-0.5% -$3.43K 0.03% 842
2019
Q1 		$687K Sell
19,600
-3
-0% -$112 0.03% 778
2018
Q4 		$651K Sell
19,603
-3,397
-15% -$146K 0.04% 725
2018
Q3 		$1.16M Sell
23,000
-200
-0.9% -$9.88K 0.05% 521
2018
Q2 		$1.39M Buy
23,200
+300
+1% +$15.5K 0.06% 362
2018
Q1 		$1.05M Buy
22,900
+800
+4% +$33.4K 0.05% 529
2017
Q4 		$881K Buy
22,100
+1,600
+8% +$63.2K 0.04% 675
2017
Q3 		$820K Hold
20,500
– – 0.04% 710
2017
Q2 		$884K Buy
20,500
+100
+0.5% +$3.56K 0.04% 627
2017
Q1 		$639K Buy
20,400
+500
+3% +$13.4K 0.03% 854
2016
Q4 		$502K Sell
19,900
-2,000
-9% -$44.7K 0.03% 1019
2016
Q3 		$542K Buy
21,900
+6,600
+43% +$149K 0.03% 962
2016
Q2 		$312K Buy
15,300
+100
+0.7% +$1.77K 0.02% 1255
2016
Q1 		$232K Buy
15,200
+100
+0.7% +$1.3K 0.01% 1334
2015
Q4 		$203K Buy
15,100
+200
+1% +$3.09K 0.01% 1359
2015
Q3 		$209K Buy
14,900
+2,200
+17% +$40.9K 0.01% 1353
2015
Q2 		$216K Buy
+12,700
New +$181K 0.01% 1386

Other funds holding SUPN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CNAM
Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return

Louisiana State Employees Retirement System's SUPN Position: Q2 2026 in Review

Louisiana State Employees Retirement System held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 25,400 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #1007.

Louisiana State Employees Retirement System first reported a position in SUPN in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.39M in Q2 2018. 61 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Louisiana State Employees Retirement System held 25,400 shares of Supernus Pharmaceuticals worth $1.18M as of Q2 2026.
  • Louisiana State Employees Retirement System left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up 0.02% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1007 holding.
  • Louisiana State Employees Retirement System first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
  • Louisiana State Employees Retirement System's Supernus Pharmaceuticals position peaked at $1.39M in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.